Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 35

    1.

    Matrix metalloproteinases at cancer tumor-host interface.

    Noël A, Jost M, Maquoi E.

    Semin Cell Dev Biol. 2008 Feb;19(1):52-60. Epub 2007 Jun 6. Review.PMID: 17625931 [PubMed - indexed for MEDLINE]Related articles

    2.

    What are subcutaneous adipocytes really good for?

    Klein J, Permana PA, Owecki M, Chaldakov GN, Böhm M, Hausman G, Lapière CM, Atanassova P, Sowiński J, Fasshauer M, Hausman DB, Maquoi E, Tonchev AB, Peneva VN, Vlachanov KP, Fiore M, Aloe L, Slominski A, Reardon CL, Ryan TJ, Pond CM, Ryan TJ.

    Exp Dermatol. 2007 Jan;16(1):45-70.PMID: 17181636 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Membrane-type 4 matrix metalloproteinase promotes breast cancer growth and metastases.

    Chabottaux V, Sounni NE, Pennington CJ, English WR, van den Brûle F, Blacher S, Gilles C, Munaut C, Maquoi E, Lopez-Otin C, Murphy G, Edwards DR, Foidart JM, Noël A.

    Cancer Res. 2006 May 15;66(10):5165-72.PMID: 16707440 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Modulation of angiogenesis during adipose tissue development in murine models of obesity.

    Voros G, Maquoi E, Demeulemeester D, Clerx N, Collen D, Lijnen HR.

    Endocrinology. 2005 Oct;146(10):4545-54. Epub 2005 Jul 14.PMID: 16020476 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Role of Gas-6 in adipogenesis and nutritionally induced adipose tissue development in mice.

    Maquoi E, Vörös G, Carmeliet P, Collen D, Lijnen HR.

    Arterioscler Thromb Vasc Biol. 2005 May;25(5):1002-7. Epub 2005 Feb 24.PMID: 15731491 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Anti-invasive, antitumoral, and antiangiogenic efficacy of a pyrimidine-2,4,6-trione derivative, an orally active and selective matrix metalloproteinases inhibitor.

    Maquoi E, Sounni NE, Devy L, Olivier F, Frankenne F, Krell HW, Grams F, Foidart JM, Noël A.

    Clin Cancer Res. 2004 Jun 15;10(12 Pt 1):4038-47.PMID: 15217936 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Membrane associated proteases and their inhibitors in tumour angiogenesis.

    Noel A, Maillard C, Rocks N, Jost M, Chabottaux V, Sounni NE, Maquoi E, Cataldo D, Foidart JM.

    J Clin Pathol. 2004 Jun;57(6):577-84. Review.PMID: 15166260 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Influence of membrane-bound tumor necrosis factor (TNF)-alpha on obesity and glucose metabolism.

    Voros G, Maquoi E, Collen D, Lijnen HR.

    J Thromb Haemost. 2004 Mar;2(3):507-13.PMID: 15009470 [PubMed - indexed for MEDLINE]Related articles

    9.

    Up-regulation of vascular endothelial growth factor-A by active membrane-type 1 matrix metalloproteinase through activation of Src-tyrosine kinases.

    Sounni NE, Roghi C, Chabottaux V, Janssen M, Munaut C, Maquoi E, Galvez BG, Gilles C, Frankenne F, Murphy G, Foidart JM, Noel A.

    J Biol Chem. 2004 Apr 2;279(14):13564-74. Epub 2004 Jan 16.PMID: 14729679 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Enhanced nutritionally induced adipose tissue development in mice with stromelysin-1 gene inactivation.

    Maquoi E, Demeulemeester D, Vörös G, Collen D, Lijnen HR.

    Thromb Haemost. 2003 Apr;89(4):696-704.PMID: 12669125 [PubMed - indexed for MEDLINE]Related articles

    11.

    Regulation of membrane-type 1 matrix metalloproteinase activity by vacuolar H+-ATPases.

    Maquoi E, Peyrollier K, Noël A, Foidart JM, Frankenne F.

    Biochem J. 2003 Jul 1;373(Pt 1):19-24.PMID: 12667140 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Deficiency of tissue inhibitor of matrix metalloproteinase-1 (TIMP-1) impairs nutritionally induced obesity in mice.

    Lijnen HR, Demeulemeester D, Van Hoef B, Collen D, Maquoi E.

    Thromb Haemost. 2003 Feb;89(2):249-55.PMID: 12574803 [PubMed - indexed for MEDLINE]Related articles

    13.

    Differential expression of plasminogen activator inhibitor-1, tumor necrosis factor-alpha, TNF-alpha converting enzyme and ADAMTS family members in murine fat territories.

    Voros G, Maquoi E, Collen D, Lijnen HR.

    Biochim Biophys Acta. 2003 Jan 3;1625(1):36-42.PMID: 12527424 [PubMed - indexed for MEDLINE]Related articles

    14.

    Nutritionally induced obesity is attenuated in transgenic mice overexpressing plasminogen activator inhibitor-1.

    Lijnen HR, Maquoi E, Morange P, Voros G, Van Hoef B, Kopp F, Collen D, Juhan-Vague I, Alessi MC.

    Arterioscler Thromb Vasc Biol. 2003 Jan 1;23(1):78-84.PMID: 12524228 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Modulation of fibrinolytic and gelatinolytic activity during adipose tissue development in a mouse model of nutritionally induced obesity.

    Lijnen HR, Maquoi E, Demeulemeester D, Van Hoef B, Collen D.

    Thromb Haemost. 2002 Aug;88(2):345-53.PMID: 12195710 [PubMed - indexed for MEDLINE]Related articles

    16.

    Stimulation of matrix metalloproteinase-9 expression in human fibrosarcoma cells by synthetic matrix metalloproteinase inhibitors.

    Maquoi E, Munaut C, Colige A, Lambert C, Frankenne F, Noël A, Grams F, Krell HW, Foidart JM.

    Exp Cell Res. 2002 Apr 15;275(1):110-21.PMID: 11925109 [PubMed - indexed for MEDLINE]Related articles

    17.

    Modulation of adipose tissue expression of murine matrix metalloproteinases and their tissue inhibitors with obesity.

    Maquoi E, Munaut C, Colige A, Collen D, Lijnen HR.

    Diabetes. 2002 Apr;51(4):1093-101.PMID: 11916931 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Matrix metalloproteinase inhibition impairs adipose tissue development in mice.

    Lijnen HR, Maquoi E, Hansen LB, Van Hoef B, Frederix L, Collen D.

    Arterioscler Thromb Vasc Biol. 2002 Mar 1;22(3):374-9.PMID: 11884277 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Expression of membrane type 1 matrix metalloproteinase (MT1-MMP) in A2058 melanoma cells is associated with MMP-2 activation and increased tumor growth and vascularization.

    Sounni NE, Baramova EN, Munaut C, Maquoi E, Frankenne F, Foidart JM, Noël A.

    Int J Cancer. 2002 Mar 1;98(1):23-8.PMID: 11857380 [PubMed - indexed for MEDLINE]Related articles

    20.

    Adipose tissue expression of gelatinases in mouse models of obesity.

    Lijnen HR, Maquoi E, Holvoet P, Mertens A, Lupu F, Morange P, Alessi MC, Juhan-Vague I.

    Thromb Haemost. 2001 Jun;85(6):1111-6.PMID: 11434693 [PubMed - indexed for MEDLINE]Related articles

    21.

    New functions of stromal proteases and their inhibitors in tumor progression.

    Noel A, Albert V, Bajou K, Bisson C, Devy L, Frankenne F, Maquoi E, Masson V, Sounni NE, Foidart JM.

    Surg Oncol Clin N Am. 2001 Apr;10(2):417-32, x-xi. Review.PMID: 11382595 [PubMed - indexed for MEDLINE]Related articles

    22.

    Membrane type 1 matrix metalloproteinase-associated degradation of tissue inhibitor of metalloproteinase 2 in human tumor cell lines.

    Maquoi E, Frankenne F, Baramova E, Munaut C, Sounni NE, Remacle A, Noël A, Murphy G, Foidart JM.

    J Biol Chem. 2000 Apr 14;275(15):11368-78.PMID: 10753951 [PubMed - indexed for MEDLINE]Related articlesFree article

    23.

    Type IV collagen induces matrix metalloproteinase 2 activation in HT1080 fibrosarcoma cells.

    Maquoi E, Frankenne F, Noël A, Krell HW, Grams F, Foidart JM.

    Exp Cell Res. 2000 Dec 15;261(2):348-59.PMID: 11112341 [PubMed - indexed for MEDLINE]Related articles

    24.

    Paradoxical stimulation of matrix metalloproteinase-9 expression in HT1080 cells by a broad-spectrum hydroxamate-based matrix metalloproteinase inhibitor.

    Maquoi E, Munaut C, Colige A, Lambert C, Frankenne F, Noël A, Grams F, Krell HW, Foidart JM.

    Ann N Y Acad Sci. 1999 Jun 30;878:744-6. No abstract available. PMID: 10415825 [PubMed - indexed for MEDLINE]Related articles

    25.

    Cell-cell and cell-matrix interactions during breast cancer progression.

    Noel A, Kebers F, Maquoi E, Foidart JM.

    Curr Top Pathol. 1999;93:183-93. Review. No abstract available. PMID: 10339911 [PubMed - indexed for MEDLINE]Related articles

    26.

    Inhibition of stromal matrix metalloproteases: effects on breast-tumor promotion by fibroblasts.

    Noël A, Hajitou A, L'Hoir C, Maquoi E, Baramova E, Lewalle JM, Remacle A, Kebers F, Brown P, Calberg-Bacq CM, Foidart JM.

    Int J Cancer. 1998 Apr 13;76(2):267-73.PMID: 9537590 [PubMed - indexed for MEDLINE]Related articles

    27.

    Inhibition of matrix metalloproteinase 2 maturation and HT1080 invasiveness by a synthetic furin inhibitor.

    Maquoi E, Noël A, Frankenne F, Angliker H, Murphy G, Foidart JM.

    FEBS Lett. 1998 Mar 13;424(3):262-6.PMID: 9539163 [PubMed - indexed for MEDLINE]Related articles

    28.

    Changes in the distribution pattern of galectin-1 and galectin-3 in human placenta correlates with the differentiation pathways of trophoblasts.

    Maquoi E, van den Brûle FA, Castronovo V, Foidart JM.

    Placenta. 1997 Jul-Aug;18(5-6):433-9.PMID: 9250706 [PubMed - indexed for MEDLINE]Related articles

    29.

    Expression of stromelysin-3 in the human placenta and placental bed.

    Maquoi E, Polette M, Nawrocki B, Bischof P, Noël A, Pintiaux A, Santavicca M, Schaaps JP, Pijnenborg R, Birembaut P, Foidart JM.

    Placenta. 1997 May;18(4):277-85.PMID: 9179921 [PubMed - indexed for MEDLINE]Related articles

    30.

    Emerging roles for proteinases in cancer.

    Noël A, Gilles C, Bajou K, Devy L, Kebers F, Lewalle JM, Maquoi E, Munaut C, Remacle A, Foidart JM.

    Invasion Metastasis. 1997;17(5):221-39. Review.PMID: 9876217 [PubMed - indexed for MEDLINE]Related articles

    31.

    [Preeclampsia resulting from placental defects: biology to clinical considerations]

    Maquoi E, Schaaps JP, Jacobs JL, Noël A, Foidart JM.

    Rev Med Liege. 1997;52(7):478-84. Review. French. No abstract available. PMID: 9289785 [PubMed - indexed for MEDLINE]Related articles

    32.

    Membrane-type matrix metalloproteinase-1 expression at the site of human placentation.

    Nawrocki B, Polette M, Marchand V, Maquoi E, Beorchia A, Tournier JM, Foidart JM, Birembaut P.

    Placenta. 1996 Nov;17(8):565-72.PMID: 8916204 [PubMed - indexed for MEDLINE]Related articles

    33.

    Cloning of choriocarcinoma cells shows that invasion correlates with expression and activation of gelatinase A.

    Crescimanno C, Foidart JM, Noël A, Polette M, Maquoi E, Birembaut P, Baramova E, Kaufmann P, Castellucci M.

    Exp Cell Res. 1996 Sep 15;227(2):240-51.PMID: 8831562 [PubMed - indexed for MEDLINE]Related articles

    34.

    Stromelysin-3 expression promotes tumor take in nude mice.

    Nöel AC, Lefebvre O, Maquoi E, VanHoorde L, Chenard MP, Mareel M, Foidart JM, Basset P, Rio MC.

    J Clin Invest. 1996 Apr 15;97(8):1924-30.PMID: 8621777 [PubMed - indexed for MEDLINE]Related articlesFree article

    35.

    Expression of gelatinases A and B and their tissue inhibitors by cells of early and term human placenta and gestational endometrium.

    Polette M, Nawrocki B, Pintiaux A, Massenat C, Maquoi E, Volders L, Schaaps JP, Birembaut P, Foidart JM.

    Lab Invest. 1994 Dec;71(6):838-46.PMID: 7807965 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data

    Search details

    » See more...